Novaliq www.novaliq.de
Novaliq是一家研究投药的公司，宗旨是开发创新药物剂型。其专利半氟化烷烃(SFA)能够用于各类给药途径，以便将药物或氧气运送到需要治疗的部位。依托其独有的生理化学特性， Novaliq目前正在开发眼科创新剂型以及器官保存解决方案，拥有若干市场前景卓著的候选产品，这些产品正处于不同的开发阶段。

Novaliq GmbH is a drug delivery company located in the Heidelberg Technology Park, Germany. They develop innovative pharmaceutical formulations based on semifluorinated alkanes (SFAs).

Their patented SFAs can be used in various routes of administration for the transport of drugs or oxygen for therapeutic purposes. Novaliq currently develops novel ophthalmic and dermatological products as well as solutions for organ preservation, based on the unique physicochemical properties of SFA.

Their first product on the market is I-Let Protect™ an organ preservation liquid based on SFA.

Besides the development of its own products and licensing them to pharmaceutical distributors, Novaliq is offering its SFA technology as a delivery platform for external co-development cooperations.